Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
UK Stocks-Factors to watch on October 2 (updated)
Brief: AstraZeneca & Daiichi Sankyo announce clinical collaboration with Summit Therapeutics
Brief: IHH Healthcare Says Supreme Court Of India Has Allowed For The Forensic Audit To Proceed
Brief: Ifinatamab Deruxtecan Biologics License Application For Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
Merck, Daiichi pull US application for second partnered cancer therapy (updated)
Merck, Daiichi Sankyo withdraw US application for lung cancer drug
Malaysia's IHH's unit appeals Tokyo court's rejection of Daiichi Sankyo damages claim (updated)
Malaysia's IHH's unit appeals dismissal of Daiichi Sankyo damages claim
AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England
Press Digest: Financial Times - September 17
India's Fortis Healthcare drops as it challenges Daiichi Sankyo case court audit order
Malaysia's IHH's unit loses Tokyo court case against Daiichi Sankyo over Fortis deal (updated)
Malaysia's IHH says Tokyo court dismisses unit's claims over Fortis stake purchase
Brief: IHH Healthcare Says Court Decided That All Of NTK's Claims Are Dismissed
Daiichi Sankyo Receives Favorable Judgment In Damage Claim Filed By Ntk
Indian court orders probe in Fortis asset diversion case, Malaysia's IHH says (updated)